Zimmer Biomet Holdings (ZBH) Common Equity (2009 - 2026)

Zimmer Biomet Holdings has reported Common Equity for 18 years, with the latest figure at $12.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 2.17% year-over-year to $12.7 billion; the trailing twelve-month figure through Mar 2026 stood at $12.7 billion (up 2.17% YoY), and the FY2025 full-year result was $12.7 billion, up 1.78% from the prior year.
• Common Equity for Q1 2026 stood at $12.7 billion, roughly flat from $12.7 billion in the prior quarter.
• The five-year high for Common Equity was $12.8 billion in Q3 2025, with the low at $12.0 billion in Q1 2022.
• Average Common Equity over 5 years is $12.4 billion, with a median of $12.5 billion recorded in 2024.
• Year-over-year, Common Equity decreased 5.05% in 2022 and increased 3.83% in 2023.
• Tracing ZBH's Common Equity over 5 years: stood at $12.0 billion in 2022, then grew by 3.83% to $12.5 billion in 2023, then dropped by 0.1% to $12.5 billion in 2024, then grew by 1.78% to $12.7 billion in 2025, then fell by 0.19% to $12.7 billion in 2026.
• The last three Common Equity figures came in at $12.7 billion (Q1 2026), $12.7 billion (Q4 2025), and $12.8 billion (Q3 2025), per Business Quant data.

Peer Comparison